Myomo, Inc. MYO
Regular-session close
After hours · Nov 20, 4:36 PM ET
- YTD
- -10.88%
- 1 year
- +12.64%
- Market cap
- 32.52M
- Revenue (ttm)
- 25.24M
- Profit margin
- -33.22%
- EPS (ttm)
- -0.37
- Shares out
- 33.70M
- Forward P/E
- -120.60
- YTD return
- -10.88%
- 1-year return
- +12.64%
- 50-day average
- 4.85
- Volume
- 381.82K
- Avg volume
- 346.56K
- Open
- 0.84
- Previous close
- 0.84
- Day's range
- 0.80 – 0.849
- 52-week range
- 0.64 – 1.86
- Beta
- 1.55
- Analysts
- Strong Buy
- Price target
- 7.67 (+845.3%)
Key statistics
- 200-day average
- 4.03
- Enterprise value
- 178.72M
- Price / sales
- 8.05
- Price / book
- 19.64
- Revenue growth
- 81.30%
- Free cash flow
- -6.20M
- Total cash
- 6.62M
- Total debt
- 234.63K
- Return on equity
- -82.54%
- Short % of float
- 2.68%
Fundamental scorecard
6 of 25 checks passed on MYO’s reported financials
6of 25 checks passed
- Value 1 of 5
- Growth 2 of 5
- Profitability 1 of 5
- Financial health 2 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2024 | Sep 1, 2024 | -0.04 | -0.03 | +0.01 | +25.00% |
| Aug 6, 2024 | Jun 1, 2024 | -0.07 | -0.03 | +0.04 | +57.14% |
| May 8, 2024 | Mar 1, 2024 | -0.09 | -0.10 | -0.01 | -11.11% |
| Mar 7, 2024 | Dec 1, 2023 | -0.05 | -0.07 | -0.02 | -40.00% |
| Nov 7, 2023 | Sep 1, 2023 | -0.08 | -0.06 | +0.02 | +25.00% |
| Aug 9, 2023 | Jun 1, 2023 | -0.04 | -0.04 | 0.00 | 0.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 13, 2024 | Craig-Hallum | main | Buy | Buy |
| Nov 12, 2024 | Ascendiant Capital | main | Buy | Buy |
| Aug 19, 2024 | Ascendiant Capital | main | Buy | Buy |
| Aug 12, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Jul 31, 2024 | Craig-Hallum | init | — | Buy |
| Jul 9, 2024 | Lake Street | main | Buy | Buy |
About Myomo, Inc.
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- myomo.com
News
Your note
Sign in to keep a note on MYO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CROWLEY THOMAS ALOYSIUS JR | Director | Stock Award(Grant) | Jun 4, 2024 | 42,028 |
| GETZ HEATHER C | Director | Stock Award(Grant) | Jun 4, 2024 | 12,034 |
| GUDONIS PAUL R | Chief Executive Officer | Stock Award(Grant) | Jun 4, 2024 | 959,845 |
| HENRY DAVID A | Chief Financial Officer | Stock Award(Grant) | Jun 4, 2024 | 414,419 |
| KIRK THOMAS F | Director | Stock Award(Grant) | Jun 4, 2024 | 248,533 |
| KNAPP AMY K | Director | Stock Award(Grant) | Jun 4, 2024 | 91,645 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Rosalind Advisors, Inc. | 9.99% | 3,021,391 | 18.22M | Sep 29, 2024 |
| AIGH Capital Management LLC | 9.19% | 2,778,848 | 16.76M | Sep 29, 2024 |
| Vanguard Group Inc | 4.11% | 1,242,907 | 7.49M | Sep 29, 2024 |
| Essex Investment Management Co LLC | 2.97% | 899,135 | 5.42M | Sep 29, 2024 |
| Legato Capital Management LLC | 1.02% | 307,271 | 1.85M | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.76% | 229,098 | 1.38M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.86% | 866,170 | 5.22M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.14% | 346,162 | 2.09M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.42% | 127,531 | 769.01K | Oct 30, 2024 |
| 1290 Fds-1290 Essex Small Cap Growth Fd | 0.38% | 114,763 | 692.02K | Jul 30, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.22% | 67,500 | 407.02K | Sep 29, 2024 |
| iShares Micro Cap ETF | 0.21% | 63,396 | 382.28K | Oct 30, 2024 |
